Radiofrequency ablation of liver metastases from cancer of unknown primary site
    PDF
    Cite
    Share
    Request
    Interventional Radiology - Original Article
    P: 297-302
    December 2009

    Radiofrequency ablation of liver metastases from cancer of unknown primary site

    Diagn Interv Radiol 2009;15(4):297-302
    1. Departments of Radiology, Red Cross Hospital Athens, Greece
    2. Departments of Radiology, Alexandra General Hospital Athens, Greece
    3. Departments of Radiology, Red Cross Hospital Athens, Greece
    4. Department of Radiology, Red Cross Hospital, Athens, Greece
    5. Departments of Radiology, Sotiria Hospital Athens, Greece
    No information available.
    No information available
    Received Date: 12.02.2008
    Accepted Date: 01.02.2009
    PDF
    Cite
    Share
    Request

    ABSTRACT

    PURPOSE

    This retrospective study was performed to review the efficacy of local radiofrequency ablation (RFA) in all the management of liver cancer of unknown primary site (CUP), and to identify possible prognostic features and complications that affect the efficacy of this treatment on survival.

    MATERIALS AND METHODS

    From April 2003 to December 2007, 22 patients (15 men, 7 women) with a total of 36 liver metastasis of CUP and poor response to prior systemic chemotherapy were treated with computed tomography-guided RFA. The median age of patients was 66 years. All patients (22/22) had 1-, 3-, and 6- month follow-up and 8/22 of them had a 12-month followup.

    RESULTS

    The overall median survival of all 22 patients was 10.9 months. Survival was better in patients with lesions 3 cm or smaller. No severe complications, including local seeding, were occured.

    CONCLUSION

    Our study revealed that RFA appears to be an effective, safe and relatively simple alternative procedure for the local ablation of these lesions. These results are more encouraging for lesions 3 cm or smaller, all of which were successfully treated, as proved by the imaging criteria and the statistical analysis. Further prospective trials are needed to determine whether RFA should be proposed for standard protocols.

    Keywords: neoplasms, unknown primary, liver, radiofrequency ablation

    References

    2024 ©️ Galenos Publishing House